Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor

Creative Commons License

Cetin B., Kaplan M. A., Berk V., Tufan G., Benekli M., Isikdogan A., ...Daha Fazla

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, cilt.43, sa.1, ss.28-32, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1093/jjco/hys175
  • Dergi Adı: JAPANESE JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.28-32
  • Gazi Üniversitesi Adresli: Evet

Özet

Surgical resection of asymptomatic primary colorectal cancer in patients presenting with synchronous unresectable metastatic disease is controversial. Concerns and controversies remain over combining cytotoxic chemotherapy with bevacizumab in this patient population.